Tag: Stock pick

When it comes to ASX dividend stocks, IPH Ltd (ASX: IPH) is a long-term high-yielding player.

At the time of writing, IPH shares are up around 1% and changing hands for $4.14 a piece.

The ASX dividend stock has performed well so far in 2026, climbing over 15% year to date. The share price has also rebounded an impressive 30% since hitting an all-time low of just $3.19 per share in March this year.

It hasn’t all been smooth sailing, though. The company has faced significant headwinds over the past few years, which have sent its share price crashing.

These include, underperformance by its Australia and New Zealand segments, concerns about transition to a new CEO, a declining volume of US patent filings, and currency volatility.

Since October 2022, when IPH shares spiked close to an all-time high of $9.22 a piece, they began a consistent and relentless tumble through to the end of 2025.

The most significant crash followed the company’s FY25 results in mid-August last year, when the share price fell 20% in just one day. 

So, while the year-to-date share price gains are impressive. Over the past 12 months, IPH shares are still down around 18%. 

Some investors might be put off by the falling share price and company headwinds. But I think the latest share price crash presents a rare opportunity to buy the high-yielding ASX dividend stock for cheap.

Here are three reasons why.

1. IPH has paid a reliable and consistent high-yield dividend

The ASX dividend stock has paid a regular semi-annual dividend payment to shareholders for years. IPH started paying a dividend to investors in 2016 and has gradually increased its annual payout each year since 2018.

It pays a high dividend yield, too. IPH maintains a high payout ratio of 80% to 90%. In March, the company paid its shareholders an interim dividend of 19 cents per share, 20% franked. That implies a yield of around 9.4% at the time of writing.

2. It has a defensive market position

IPH is an intellectual property (IP) services provider. Because IP protection is a legal necessity regardless of economic cycles, the company benefits from consistent cash flow and solid earnings visibility, even amid sharemarket volatility.

3. It has secured new executive leadership

Part of the headwinds facing IPH has been uncertainty about the company’s ability to transition its leadership to a new CEO. 

But in May, the company announced it had recruited for the position, and Tony O’Malley began the role as Managing Director and Chief Executive Officer earlier this month. 

He replaced Andrew Blattman, who flagged his retirement in November. Blattman will stay with the company for a transition period and continue providing support until 30 November 2026.

The update has clearly helped to ease some investor concerns and improve sentiment.

The post 1 ASX dividend stock down 18% I’d buy today! appeared first on The Motley Fool Australia.

More reading

• How much passive income can I earn off a $50,000 portfolio?
• How much do I need in my superannuation to get $50k per year in passive income?
• 2 ASX dividend shares that yield 9% (or even higher)
• How much do I need in my superannuation to get $6,000 per month in passive income?
• How much do I need in superannuation to receive $5,500 per month in passive income?

Motley Fool contributor Samantha Menzies has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended IPH Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

CSL Ltd (ASX: CSL) shares are climbing higher into the green in Thursday lunchtime trade.

At the time of writing, the shares are up around 0.5% and changing hands for $122.29 a piece.

Today’s uptick means the ASX biotech shares have now climbed around 15% over the past month and have rebounded 33% since a 15-year low in early June.

But there is still a long way for CSL shares to go before they’ve recouped the huge amount of losses shed over the past 18 months.

The shares are still down around 29% for the year-to-date and are 51% lower than trading prices 12 months ago.

The latest rebound is certainly a step in the right direction. But the question now is, can CSL shares keep climbing higher?

Here’s what the experts expect from the biotech stock over the next 12 months.

Buy, sell or hold: Here’s what brokers tip for CSL shares

It looks like market sentiment for CSL shares has shifted recently. Previously, brokers were incredibly bullish about the ASX healthcare shares and were confident of a strong upside ahead.

But now it looks like there’s a little more caution in the market.

Market Index data shows that the majority of brokers now have a hold rating on CSL shares. The $131.48 target price implies a potential 8% upside at the time of writing.

TradingView data also shows some ratings downgrades. Out of 18 analysts, 10 now have a hold stance on the biotech company’s shares, and another eight have a hold or strong hold rating.

The average target price is a little higher at $140.15, which implies a potential 15% upside at the time of writing. But some are still bullish that CSL shares could climb 64% to $199.68 over the next 12 months.

Morgans is one of the more optimistic brokers. It has a buy rating with a price target of $147.59, implying a robust upside ahead. The broker notes that CSL’s long-term story remains intact. However, it thinks that a sustained recovery in sentiment may take several quarters to fully materialise while investors wait for clear improvement in the company’s financials.

Elsewhere, the team at Macquarie is more cautious. The broker has a lower price target of $114 and a neutral stance. It cites uncertainty across CSL’s core plasma and albumin businesses, as well as ongoing competitive pressures.

My view on CSL shares

The latest rebound shows that investors are now looking forward to the company’s FY26 results announcement and any sign that management has been able to improve operations. 

I think there is a lot of potential for the company over the next few years. After all, CSL is operating in a high-growth market, and its blood plasma division dominates the market for rare blood disorders and immunoglobulin products. 

Global demand for plasma therapies is strong and growing, too. There is recurring demand and limited competition, which makes CSL well-placed to carve out a significant portion of the market.

I think that once CSL is able to turn around its financials, investor confidence will follow.

The post Here’s what brokers tip for CSL shares over the next 12 months appeared first on The Motley Fool Australia.

More reading

• How have CSL shares performed over 10 years?
• The Macquarie share price just hit a new record high
• How I’d invest $10,000 in ASX shares for the next decade
• What did the market look like 10 years ago? Here’s what’s changed for the ASX 200
• Would Warren Buffett buy CSL shares?

Motley Fool contributor Samantha Menzies has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended CSL and Macquarie Group. The Motley Fool Australia has recommended CSL and Macquarie Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The analyst team at Macquarie has recently issued new research notes on various companies in the resources sector.

I’ve picked out two ASX shares which might be of interest, respectively in the gas and mineral sands sectors.

Let’s have a look at who they like.

Amplitude Energy Ltd (ASX: AEL)

Macquarie notes in its recent report on Amplitude that the company is on track for a final investment decision for its East Coast Gas Project this quarter and first production in FY28.

Amplitude shored up the project in May, buying half of the Artisan gas field in the offshore Otway Basin from Beach Energy Ltd (ASX: BPT) for $58.3 million.

Amplitude Managing Director Jane Norman said regarding the deal:

Producing Artisan through Amplitude Energy’s existing infrastructure allows faster and lower-cost development of this gas for the east coast domestic market. Artisan development costs will significantly benefit from leveraging the existing East Coast Supply Project (ECSP) program and our readily-available infrastructure. This is a win-win for Amplitude, O.G. Energy and Beach with respect to optimising our respective Otway Basin positions. We expect to rapidly move to FID on the development phase of the ECSP over the next few months while the drilling of the Juliet and Annie wells is conducted, with Juliet now brought forward and drilling expected to commence by late July or early August.

Macquarie said there was downside pressure on gas prices from the Federal Government’s gas reservation scheme, but also noted that 80% of Amplitude’s 2026 gas volumes were under contract.

They added:

Latest gas market interventions drive a structural oversupply in domestic gas markets, but we believe incentives may ultimately be required to encourage investment in backfill supply projects (eg. carve outs, subsidies, creation of domestic trading credit market).

Macquarie has a price target of $2.15 on Amplitude shares compared to $1.49 currently.

Iluka Resources Ltd (ASX: ILU)

Macquarie said zircon pricing improved in the first quarter of 2026, with improved Chinese sentiment and tight premium zircon supply supporting the market.

In contrast, titanium dioxide markets remained weak, while rutile prices were also depressed through the second quarter, Macquarie said.

Despite that weakness, Macquarie has a bullish share price target on the stock of $8 compared to $6.30 currently.

The broker added:

While we see early signs of recovery in zircon markets, titanium dioxide feedstock markets remain weak and continue to present an earnings headwind for ILU. Construction of Eneabba Phase 3 remains underway, with completion targeted for 2HCY27, requiring investors to maintain a longer-term investment horizon.

The post A miner and an energy company to buy according to Macquarie appeared first on The Motley Fool Australia.

More reading

• Why this ASX energy stock could be set to rise 80%: Expert
• 2 ASX growth shares with strong potential to buy
• Amplitude Energy shares could be set to soar 90%: Expert
• Are these oversold ASX shares too good to pass up?
• This ASX gas company could more than double in value: Broker

Motley Fool contributor Cameron England has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Macquarie Group. The Motley Fool Australia has recommended Macquarie Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

ResMed Inc (ASX: RMD) shares have fallen by more than 25% over the past year, which begs the question: Is now the time to buy in?

ResMed shares looking cheap according to analysts

The analyst team at Morgans has run the ruler over the company, and has a buy recommendation on the stock and a bullish share price target, which we’ll get to shortly.

The reason the Morgans team had another look at ResMed was because of the company’s recent move to sell its MatrixCare division for US$490 million, with that sale expected to be completed in the first quarter of FY27.

ResMed said the sale would allow it to focus more strongly on its core business.

As it said:

This move reflects Resmed’s 2030 strategy by focusing on high-growth, scalable opportunities in sleep health, breathing health and connected home-based healthcare. The divestiture also strengthens Resmed’s ability to reallocate capital and resources toward innovation, operational scale and long-term value creation across its connected, home-based care ecosystem.

MatrixCare is a software business focused on “nursing, senior living and long-term care, life planning communities, and home health and hospice care”.

The Morgans team said they believed the transaction made sense as it would simplify the ResMed business.

They added:

Importantly, net proceeds will largely be returned to shareholders via an accelerated share repurchase (ASR), which should substantially offset earnings dilution from both the MatrixCare disposal and the recently completed Noctrix acquisition, while FY26 guidance has been reaffirmed.

Morgans said MatrixCare, which ResMed acquired for US$750 million in 2018, had been a disappointing acquisition for the company.

Morgans said:

During this time, earnings increased from ~US$30m to ~US$55m, implying modest long-term earnings growth. While this reflects poorly on the original acquisition, we believe exiting today is preferable to continuing to allocate capital toward a mature business with limited strategic alignment.

ResMed target price has been reduced

Overall, Morgans remains positive on ResMed’s outlook; however, they slightly reduced their price target to $41.72.

As they said:

We view RMD’s fundamentals as sound, with consistent execution, strong cash generation and structural growth tailwinds from expanding diagnosis and resupply. We have a BUY rating with a sum of the parts/discounted cash flow target price of $40.97.

ResMed shares were changing hands for $28.25 on Thursday.

The company is valued at $40.06 billion and pays an unfranked 1.23% dividend yield.

ResMed will report its fourth quarter earnings on 6 August.

The post How much could ResMed shares rise according to Morgans? appeared first on The Motley Fool Australia.

More reading

• Buy, hold, sell: Pro Medicus, Worley, and ResMed shares
• 3 ways to get from $100,000 to $500,000 in retirement savings
• 5 things to watch on the ASX 200 on Thursday
• How I’d invest $10,000 in ASX shares for the next decade
• 10 fantastic ASX shares to buy for FY27

Motley Fool contributor Cameron England has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended ResMed. The Motley Fool Australia has positions in and has recommended ResMed. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Dividend winners do not usually begin with a dividend cut.

But that is what makes Jumbo Interactive Ltd (ASX: JIN) an interesting ASX income share to watch.

The Jumbo Interactive share price remains down more than 25% over the past 12 months, despite recovering from its recent 52-week low of $5.85 to trade back above $7.

The worst of the sentiment followed a Morgan Stanley downgrade in June. The broker lowered its rating to hold and slashed its 12-month price target from $14.50 to $8.40. Jumbo shares were subsequently whacked by around 17% at one point.

Yet underneath the negative sentiment sits a profitable, growing business offering a dividend yield of approximately 6% at the time of writing.

That payout has recently been reduced. However, the decision may strengthen Jumbo’s capacity to deliver more sustainable income over the long term.

Why cut a healthy dividend?

Jumbo’s leadership has deliberately lowered the company’s dividend payout ratio following its acquisitions of Dream Car Giveaways in the United Kingdom and Dream Giveaway in the United States.

That means more cash can remain inside the business to reduce debt and strengthen the balance sheet.

Income investors may understandably prefer receiving that cash today. However, paying down acquisition debt can reduce financial risk and give Jumbo greater flexibility long term.

It could also create an interesting future catalyst.

Should debt fall, earnings continue growing, and the board eventually restore a higher payout ratio, shareholders could benefit from a larger dividend and a potential valuation re-rating.

There are no guarantees, of course. Yet the current yield of around 6%, before considering franking credits, already looks competitive beside cash investments – even after the temporary payout reduction.

The underlying business is still growing

The recent trading update suggests Jumbo’s fundamentals are stronger than its falling share price might imply.

Management expects FY26 underlying operating earnings (EBITDA) of between $82 million and $85 million. That would represent growth of between 20% and 24%.

Underlying profits (NPAT) are forecast to rise by between 13% and 18% to between $48 million and $50 million.

Dream Giveaway US is the standout performer. Jumbo almost doubled its underlying earnings guidance from US$2.7 million to US$3 million to US$5.2 million to US$5.5 million.

Canadian managed services growth was also upgraded from 20% to 25% to 35% to 45%, supported by new business wins, product investment, and favourable campaign timing.

The improving performance of these newer operations matters because Jumbo is gradually becoming less dependent on Australian lottery ticket sales.

Its growing international prize-draw, software platform, and managed services businesses could provide additional earnings streams across the United States, the United Kingdom, and Canada.

Why dividends may matter more

Jumbo’s income potential could also attract greater attention following Australia’s capital gains tax reforms.

From 1 July 2027, the existing 50% CGT discount will be replaced by cost-base indexation and a minimum 30% tax rate on real capital gains. The reforms apply to gains arising after that date.

Investors should never choose a company solely because of tax changes. Total shareholder returns still depend on the quality of the business, its earnings, valuation, and future prospects.

However, where capital gains receive less favourable treatment, dependable dividends may become a more valuable component of investor returns.

What could go wrong?

The concerns surrounding Jumbo are real.

Its reseller agreements with the Lottery Corporation Ltd (ASX: TLC) run until 2030, and investors remain uncertain about renewal terms and future margins. The Dream businesses carry integration risk, while regulatory changes could affect the UK prize-draw market.

Bell Potter has retained its hold rating and set a $7.20 price target, citing ongoing concerns about Australian market share.

Jumbo is not a smooth-sailing dividend investment. But with earnings growing, international diversification gaining momentum, debt reduction underway, and a yield of around 6%, this beaten-down ASX share could be a hidden dividend winner worth watching.

The post Is this beaten-down ASX software stock hiding a dividend winner? appeared first on The Motley Fool Australia.

More reading

• Is this ASX consumer discretionary stock a buy after jumping 10% yesterday?
• 5 things to watch on the ASX 200 on Friday
• Downgrade alert! 4 ASX shares re-rated by experts this week

The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Jumbo Interactive and The Lottery Corporation. The Motley Fool Australia has recommended Jumbo Interactive and The Lottery Corporation. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The AMP Ltd (ASX: AMP) share price is in focus after the company flagged an expected underlying net profit after tax (NPAT) of $170–180 million for the first half of 2026, driven by stronger China partnerships and increased investment income.

What did AMP report?

• Expected NPAT (underlying) for 1H26: $170–180 million
• China partnerships contributed approximately $56 million, a 24% increase over 2H25
• Group investment income added roughly $5 million compared to 1H25, benefiting from higher interest rates
• Platforms saw a favourable $5 million impact from the North Guarantee
• Recognition of approximately $13 million in carried interest from asset sales
• Negative revaluation of about $12 million in ‘Other Partnerships’ sponsor investments

What else do investors need to know?

AMP has received a portion of its carried interest tied to the sale of a 51% stake in legacy fund assets previously held by AMP Capital’s International Infrastructure Equity business. The sale, managed by DigitalBridge, delivered $13 million in carried interest recognised in the half-year result.

There is still potential for further carried interest earnings if the remaining 49% interest is sold, but this remains subject to conditions and regulatory approvals, so nothing is guaranteed at this stage.

AMP’s full 1H26 results will be released on 6 August 2026, with the company planning to provide more detail on its FY26 outlook at that time.

What’s next for AMP?

Investors looking ahead will be waiting on the August results announcement for additional information about AMP’s earnings trajectory and future guidance for full-year 2026. The business will likely update shareholders on carried interest developments and its strategic direction in China and other partnerships.

With earnings up on stronger investment income and China activity, AMP appears positioned to keep building momentum as market conditions evolve.

AMP Limited share price snapshot

Over the past 12 months, AMP shares have risen 21%, outperforming the S&P/ASX 200 Index (ASX: XJO), which has risen 2% over the same period.

View Original Announcement

The post AMP expects higher 1H26 earnings on China growth appeared first on The Motley Fool Australia.

More reading

• Why are AMP shares trading higher today?
• Netwealth delivers record FUA in June 2026 quarter
• Could US expansion send Zip shares soaring further?
• Perpetual receives sweetened $22.07 EQT AB takeover bid
• 5 things to watch on the ASX 200 on Thursday

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

Shares in AMP Ltd (ASX: AMP) spiked sharply in early trade after the company provided a positive earnings update for the first half.

AMP’s first half will trounce last year’s result

The financial services company said in a statement to the ASX that it expected underlying net profit to come in at $170 to $180 million.

This compares to $131 million for the same period last year.

There were several reasons for the upgrade, including a stronger contribution from AMP’s China business, a favourable investment income contribution, and a one-off contribution from the partial sale of assets in a legacy fund.

On the latter, AMP had this to say:

As disclosed on 12 February 2026, AMP’s right to receive carried interest in a legacy fund in which DigitalBridge had sold a 51% interest in remaining assets was subject to certain conditions, including sale of the remaining interest in those assets and regulatory approvals. Further to that announcement, DigitalBridge has chosen to pay a portion of the carried interest to AMP, associated with the sale of the 51% interest, prior to the sale of the remaining interest in the assets. The other sale conditions have been satisfied.

The sale netted AMP about $13 million, and the company said there was the possibility of further payments in the future.

AMP said:

There remains the potential to realise additional carried interest from the sale of the remaining 49% interest in the assets. Entitlement to any further carried interest is subject to conditions, is uncertain and cannot be determined until the sale of the remaining interest.

AMP also said it would recognise a negative revaluation of $12 million in sponsor investments.

AMP shares trading strongly

AMP shares traded as high as $1.89 on the news before settling back to be 2% higher at $1.76.

Over a one-year period, the stock is up 17.8%.

AMP also recently completed its $150 million share buyback, which bought back about 99 million shares at an average price of $1.52.

AMP chair Blair Vernon said re the buyback:

The completion of this Buyback reflects our disciplined approach to capital management, while maintaining a strong and resilient balance sheet. As we focus on driving momentum in our wealth businesses and delivering strong cash generation, we remain committed to returning surplus capital to shareholders.

AMP will announce its half-year results on August 6.

The company is valued at $4.21 billion and is currently paying a 20% franked dividend yield of 2.31%.

The post Why are AMP shares trading higher today? appeared first on The Motley Fool Australia.

More reading

• AMP expects higher 1H26 earnings on China growth
• Buying AMP shares? Here’s the dividend yield you’ll get today
• 5 best ASX 200 financial shares of FY26
• Are AMP shares a good buy for passive income?
• Here are the top 10 ASX 200 shares today

Motley Fool contributor Cameron England has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

If you can pick the right companies, buying into ASX mining shares as the company progresses from explorer to miner can be a lucrative way to invest.

Naturally, picking the right companies to invest in is the key.

I’ve had a look at the reports coming out of broker Shaw and Partners this week, and there are two companies they think could do extremely well.

Let’s see who they like.

Brightstar Resources Ltd (ASX: BTR)

Brightstar shares have not performed well over the past year, sliding just more than 40% to be changing hands for 32 cents.

The company in recent days released a new mineral resource estimate for its Sandstone project, saying the amount of gold contained on a measured and indicated resource basis had more than doubled to 1.1 million ounces.

Overall, the company said it had resources of 4.5 million ounces.

The company also said drilling was ongoing at Sandstone, with four rigs operating.

Brightstar Managing Director Alex Rovira said:

A huge amount of drilling has been completed at the project, so it is encouraging to see the results reflected in this interim MRE update. The result has exceeded expectations for Mineral Resource growth in this first update, with the strategic focus to date on improving the quality of the Mineral Resource ahead of the prefeasibility study and eventual mining development. Importantly, the project now hosts 1.1Moz of Indicated-classified Mineral Resources. This higher confidence is crucial for the delivery of our PFS, and we are targeting further increases in subsequent estimates with drilling underway now at key deposits such as Bull Oak, Indomitable and Two Mile Hill-Shillington.

Shaw and Partners said the project, “in our view, the project suffers from perceptions of uncertainty”.

They added:

Sandstone currently has no mine study, no Reserve and limited measured and indicated resources, at least prior to today. This Resource upgrade could help persuade that Sandstone has a critical mass of gold to justify development.

Shaw and Partners has a price target of $1.23 on Brightstar shares.  

Global Lithium Resources Ltd (ASX: GL1)

Shaw and Partners said GL1’s recent deal to buy a nickel-copper processing plant from IGO Ltd (ASX: IGO)’s Nova division, which it could convert to process lithium ore from its Manna lithium project, was a positive.

They added:

The acquisition will accelerate Manna’s development pathway by leveraging Nova’s commissioned infrastructure rather than GL1 having to construct a standalone processing plant. This will well and truly allow GL1 to capture the forecast 2027/28 lift in lithium demand and position GL1 as a near-term producer.

Shaw and Partners has a price target of $1.75 on GL1 shares compared to 46.5 cents currently.

The post 2 ASX mining project developers which could more than triple in value appeared first on The Motley Fool Australia.

More reading

• Up 11% in a week, why is this ASX All Ords gold stock outperforming again today?
• Looking for returns of greater than 250%? One broker has tipped this ASX gold stock to fly

Motley Fool contributor Cameron England has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

ASX stocks are a fantastic place to invest for passive income in retirement. But, I’d only choose investments that I’m confident can provide rewarding and resilient payouts.

Not every business can be reliable, partly because of the industry they operate in. Miners, for example, are heavily exposed to movements in resources prices – this can lead to large rises and large declines of resource prices (and dividend payouts).

There are plenty of great dividend options beyond the large ASX blue-chip shares. I’m going to outline two I’d happily invest $15,000 into.

Rural Funds Group (ASX: RFF)

I think Rural Funds is one of the leading real estate investment trusts (REITs) for passive income. The business owns a portfolio of farms across the country, including almonds, macadamias, cattle, vineyards, and cropping.

Having this investment gives Aussies diversification because Rural Funds offers something different to most other ASX dividend shares, and its own portfolio is diversified across various food segments.

Rural Funds recently took the responsible decision to sell some of its farms to improve its debt position, and this is also expected to improve its adjusted funds from operations (AFFO) – that’s the net rental profit.

The business’ FY26 payout of 11.73 cents per unit translates into a distribution yield of 5.3%, which I’d describe as a solid starting yield for retirement. It hasn’t ever reduced its cash payout since it started paying more than a decade ago.

The payout can increase in the future thanks to its built-in rental indexation. Most of the farms have rental increases that are fixed, or linked to inflation, plus market reviews.

Future Generation Global (ASX: FGG)

Another ASX stock I want to highlight is the listed investment company (LIC) Future Generation Global, an investment vehicle that gives exposure to the global share market.

All of the fund managers involved in the LIC work for free so that Future Generation Global can donate 1% of its net assets each year to youth mental charities. The LIC is invested in more than a dozen different funds from different fund managers, giving shareholders exposure to more than 3,000 underlying shares – that’s great diversification!

The business is able to provide investors with a solid dividend thanks to all of the investment returns it has already made over previous years and continues to make.

Future Generation Global recently lifted its FY26 interim dividend by 5% year over year, taking its annualised payout to 8.4 cents per share. This translates into a forward grossed-up dividend yield of around 7%, including franking credits, at the time of writing. I think that’s a wonderful yield for people in retirement. The ASX stock has increased its payout each year since FY19, so it has given investors several years of dividend hikes already, and I expect more in the coming years.

The post How to invest $15,000 for passive income in retirement appeared first on The Motley Fool Australia.

More reading

• How much superannuation is needed to target a $100,000 annual passive income?
• Why this ASX dividend share is a retiree’s dream for FY27
• How should I invest my money in FY27?
• How much is needed in superannuation to target a $70,000 annual passive income?
• How much is needed in superannuation to target $60,000 in annual passive income?

Motley Fool contributor Tristan Harrison has positions in Future Generation Global and Rural Funds Group. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has positions in and has recommended Rural Funds Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The Netwealth Group Ltd (ASX: NWL) share price is in focus after the company reported record funds under administration (FUA) of $135.7 billion, up 20% on last year, and strong quarterly inflows of $8.4 billion.

What did Netwealth report?

• Total FUA grew 20.3% year-on-year to a record $135.7 billion
• June quarter custodial FUA inflows of $8.4 billion, up 11% on the prior period
• Net flows of $3.2 billion for the quarter, supported by new and existing intermediary relationships
• Record Managed Account funds under management (FUM) of $30.5 billion, up 30% on last year
• Number of customer accounts increased by 12.4% year-on-year to 182,276
• EBITDA margin for FY26 expected at approximately 49%

What else do investors need to know?

Netwealth reported market conditions improved in the June quarter, contributing $6.7 billion to FUA. While large outflows from a few ultra-high-net-worth clients affected net flows, these accounts have largely stayed on the platform and continue to contribute to total FUA.

The platform benefited from 75 new intermediary relationships and launched several enhancements, including “Nova”, a generative AI virtual assistant for advisers, new trading features, and upgraded reporting tools. The company also expanded its relationship with Morgan Stanley to provide new platform solutions.

On the regulatory front, Netwealth progressed its RISE governance program, in line with APRA requirements, and kicked off a project to accelerate product development with technology and AI-driven tools.

What’s next for Netwealth?

Netwealth expects to maintain strong profitability and a robust balance sheet. For FY27, the company is targeting FUA net flows between $18 billion and $20 billion—an increase of up to 30%—reflecting ongoing momentum and new growth initiatives.

The company plans continued investment in technology and expects to maintain a solid EBITDA margin of around 47% in FY27, as growth-focused projects ramp up. Netwealth will announce its full-year FY26 results on 26 August 2026.

Netwealth share price snapshot

Over the past 12 months, Netwealth shares have declined 34%, trailing the S&P/ASX 200 Index (ASX: XJO), which has risen 3% over the same period.

View Original Announcement

The post Netwealth delivers record FUA in June 2026 quarter appeared first on The Motley Fool Australia.

More reading

• Could US expansion send Zip shares soaring further?
• Perpetual receives sweetened $22.07 EQT AB takeover bid
• 5 things to watch on the ASX 200 on Thursday
• Here are the top 10 ASX 200 shares today
• Evolution Mining posts record FY26 cash flow

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Netwealth Group. The Motley Fool Australia has positions in and has recommended Netwealth Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.